Hypothemycin (CAS: 76958-67-3)

Hypothemycin is a resorcylic acid lactone (RAL) natural product originally isolated from Hypomyces species and later identified as a covalent inhibitor of specific serine/threonine kinases within the Ras/MAPK pathway. In Ras-transformed cells, hypothemycin suppresses Ras-responsive gene expression and inhibits anchorage-independent growth. Mechanistically, it accelerates cyclin D1 degradation via enhancement of ubiquitination and proteasome-dependent turnover, resulting in G1-phase prolongation. It also inhibits ERK1/2 phosphorylation and modulates cytokine production during T-cell activation, indicating interference with MAPK-dependent signaling cascades. In vivo studies demonstrate tumor growth inhibition in Ras-driven models. As a member of the RAL family, hypothemycin functions through covalent targeting of kinase active-site residues, positioning it as a prototype scaffold for irreversible kinase inhibitors.